Global Rapid Acting Insulins Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 309939
  • calendar_today Published On: Jun, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Rapid Acting Insulins market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Rapid Acting Insulins market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Type 1 Diabetes accounting for % of the Rapid Acting Insulins global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Lispro segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Rapid Acting Insulins include Eli Lilly, Novo Nordisk, Sanofi, , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Rapid Acting Insulins market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Lispro

Aspart (NovoLog)

Glulisine (Apidra)

Market segment by Application, can be divided into

Type 1 Diabetes

Type 2 Diabetes

Market segment by players, this report covers

Eli Lilly

Novo Nordisk

Sanofi

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Rapid Acting Insulins product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Rapid Acting Insulins, with revenue, gross margin and global market share of Rapid Acting Insulins from 2019 to 2022.

Chapter 3, the Rapid Acting Insulins competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Rapid Acting Insulins market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Rapid Acting Insulins research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Rapid Acting Insulins

1.2 Classification of Rapid Acting Insulins by Type

1.2.1 Overview: Global Rapid Acting Insulins Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Rapid Acting Insulins Revenue Market Share by Type in 2021

1.2.3 Lispro

1.2.4 Aspart (NovoLog)

1.2.5 Glulisine (Apidra)

1.3 Global Rapid Acting Insulins Market by Application

1.3.1 Overview: Global Rapid Acting Insulins Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Type 1 Diabetes

1.3.3 Type 2 Diabetes

1.4 Global Rapid Acting Insulins Market Size & Forecast

1.5 Global Rapid Acting Insulins Market Size and Forecast by Region

1.5.1 Global Rapid Acting Insulins Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Rapid Acting Insulins Market Size by Region, (2017-2022)

1.5.3 North America Rapid Acting Insulins Market Size and Prospect (2017-2028)

1.5.4 Europe Rapid Acting Insulins Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Rapid Acting Insulins Market Size and Prospect (2017-2028)

1.5.6 South America Rapid Acting Insulins Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Rapid Acting Insulins Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Rapid Acting Insulins Market Drivers

1.6.2 Rapid Acting Insulins Market Restraints

1.6.3 Rapid Acting Insulins Trends Analysis

2 Company Profiles

2.1 Eli Lilly

2.1.1 Eli Lilly Details

2.1.2 Eli Lilly Major Business

2.1.3 Eli Lilly Rapid Acting Insulins Product and Solutions

2.1.4 Eli Lilly Rapid Acting Insulins Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Eli Lilly Recent Developments and Future Plans

2.2 Novo Nordisk

2.2.1 Novo Nordisk Details

2.2.2 Novo Nordisk Major Business

2.2.3 Novo Nordisk Rapid Acting Insulins Product and Solutions

2.2.4 Novo Nordisk Rapid Acting Insulins Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Novo Nordisk Recent Developments and Future Plans

2.3 Sanofi

2.3.1 Sanofi Details

2.3.2 Sanofi Major Business

2.3.3 Sanofi Rapid Acting Insulins Product and Solutions

2.3.4 Sanofi Rapid Acting Insulins Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Sanofi Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Rapid Acting Insulins Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Rapid Acting Insulins Players Market Share in 2021

3.2.2 Top 10 Rapid Acting Insulins Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Rapid Acting Insulins Players Head Office, Products and Services Provided

3.4 Rapid Acting Insulins Mergers & Acquisitions

3.5 Rapid Acting Insulins New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Rapid Acting Insulins Revenue and Market Share by Type (2017-2022)

4.2 Global Rapid Acting Insulins Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Rapid Acting Insulins Revenue Market Share by Application (2017-2022)

5.2 Global Rapid Acting Insulins Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Rapid Acting Insulins Revenue by Type (2017-2028)

6.2 North America Rapid Acting Insulins Revenue by Application (2017-2028)

6.3 North America Rapid Acting Insulins Market Size by Country

6.3.1 North America Rapid Acting Insulins Revenue by Country (2017-2028)

6.3.2 United States Rapid Acting Insulins Market Size and Forecast (2017-2028)

6.3.3 Canada Rapid Acting Insulins Market Size and Forecast (2017-2028)

6.3.4 Mexico Rapid Acting Insulins Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Rapid Acting Insulins Revenue by Type (2017-2028)

7.2 Europe Rapid Acting Insulins Revenue by Application (2017-2028)

7.3 Europe Rapid Acting Insulins Market Size by Country

7.3.1 Europe Rapid Acting Insulins Revenue by Country (2017-2028)

7.3.2 Germany Rapid Acting Insulins Market Size and Forecast (2017-2028)

7.3.3 France Rapid Acting Insulins Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Rapid Acting Insulins Market Size and Forecast (2017-2028)

7.3.5 Russia Rapid Acting Insulins Market Size and Forecast (2017-2028)

7.3.6 Italy Rapid Acting Insulins Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Rapid Acting Insulins Revenue by Type (2017-2028)

8.2 Asia-Pacific Rapid Acting Insulins Revenue by Application (2017-2028)

8.3 Asia-Pacific Rapid Acting Insulins Market Size by Region

8.3.1 Asia-Pacific Rapid Acting Insulins Revenue by Region (2017-2028)

8.3.2 China Rapid Acting Insulins Market Size and Forecast (2017-2028)

8.3.3 Japan Rapid Acting Insulins Market Size and Forecast (2017-2028)

8.3.4 South Korea Rapid Acting Insulins Market Size and Forecast (2017-2028)

8.3.5 India Rapid Acting Insulins Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Rapid Acting Insulins Market Size and Forecast (2017-2028)

8.3.7 Australia Rapid Acting Insulins Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Rapid Acting Insulins Revenue by Type (2017-2028)

9.2 South America Rapid Acting Insulins Revenue by Application (2017-2028)

9.3 South America Rapid Acting Insulins Market Size by Country

9.3.1 South America Rapid Acting Insulins Revenue by Country (2017-2028)

9.3.2 Brazil Rapid Acting Insulins Market Size and Forecast (2017-2028)

9.3.3 Argentina Rapid Acting Insulins Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Rapid Acting Insulins Revenue by Type (2017-2028)

10.2 Middle East & Africa Rapid Acting Insulins Revenue by Application (2017-2028)

10.3 Middle East & Africa Rapid Acting Insulins Market Size by Country

10.3.1 Middle East & Africa Rapid Acting Insulins Revenue by Country (2017-2028)

10.3.2 Turkey Rapid Acting Insulins Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Rapid Acting Insulins Market Size and Forecast (2017-2028)

10.3.4 UAE Rapid Acting Insulins Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Rapid Acting Insulins Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Rapid Acting Insulins Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Rapid Acting Insulins Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Rapid Acting Insulins Revenue (USD Million) by Region (2017-2022)

Table 5. Global Rapid Acting Insulins Revenue Market Share by Region (2023-2028)

Table 6. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 7. Eli Lilly Major Business

Table 8. Eli Lilly Rapid Acting Insulins Product and Solutions

Table 9. Eli Lilly Rapid Acting Insulins Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Novo Nordisk Corporate Information, Head Office, and Major Competitors

Table 11. Novo Nordisk Major Business

Table 12. Novo Nordisk Rapid Acting Insulins Product and Solutions

Table 13. Novo Nordisk Rapid Acting Insulins Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Sanofi Corporate Information, Head Office, and Major Competitors

Table 15. Sanofi Major Business

Table 16. Sanofi Rapid Acting Insulins Product and Solutions

Table 17. Sanofi Rapid Acting Insulins Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Global Rapid Acting Insulins Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 19. Global Rapid Acting Insulins Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 20. Breakdown of Rapid Acting Insulins by Company Type (Tier 1, Tier 2 and Tier 3)

Table 21. Rapid Acting Insulins Players Head Office, Products and Services Provided

Table 22. Rapid Acting Insulins Mergers & Acquisitions in the Past Five Years

Table 23. Rapid Acting Insulins New Entrants and Expansion Plans

Table 24. Global Rapid Acting Insulins Revenue (USD Million) by Type (2017-2022)

Table 25. Global Rapid Acting Insulins Revenue Share by Type (2017-2022)

Table 26. Global Rapid Acting Insulins Revenue Forecast by Type (2023-2028)

Table 27. Global Rapid Acting Insulins Revenue by Application (2017-2022)

Table 28. Global Rapid Acting Insulins Revenue Forecast by Application (2023-2028)

Table 29. North America Rapid Acting Insulins Revenue by Type (2017-2022) & (USD Million)

Table 30. North America Rapid Acting Insulins Revenue by Type (2023-2028) & (USD Million)

Table 31. North America Rapid Acting Insulins Revenue by Application (2017-2022) & (USD Million)

Table 32. North America Rapid Acting Insulins Revenue by Application (2023-2028) & (USD Million)

Table 33. North America Rapid Acting Insulins Revenue by Country (2017-2022) & (USD Million)

Table 34. North America Rapid Acting Insulins Revenue by Country (2023-2028) & (USD Million)

Table 35. Europe Rapid Acting Insulins Revenue by Type (2017-2022) & (USD Million)

Table 36. Europe Rapid Acting Insulins Revenue by Type (2023-2028) & (USD Million)

Table 37. Europe Rapid Acting Insulins Revenue by Application (2017-2022) & (USD Million)

Table 38. Europe Rapid Acting Insulins Revenue by Application (2023-2028) & (USD Million)

Table 39. Europe Rapid Acting Insulins Revenue by Country (2017-2022) & (USD Million)

Table 40. Europe Rapid Acting Insulins Revenue by Country (2023-2028) & (USD Million)

Table 41. Asia-Pacific Rapid Acting Insulins Revenue by Type (2017-2022) & (USD Million)

Table 42. Asia-Pacific Rapid Acting Insulins Revenue by Type (2023-2028) & (USD Million)

Table 43. Asia-Pacific Rapid Acting Insulins Revenue by Application (2017-2022) & (USD Million)

Table 44. Asia-Pacific Rapid Acting Insulins Revenue by Application (2023-2028) & (USD Million)

Table 45. Asia-Pacific Rapid Acting Insulins Revenue by Region (2017-2022) & (USD Million)

Table 46. Asia-Pacific Rapid Acting Insulins Revenue by Region (2023-2028) & (USD Million)

Table 47. South America Rapid Acting Insulins Revenue by Type (2017-2022) & (USD Million)

Table 48. South America Rapid Acting Insulins Revenue by Type (2023-2028) & (USD Million)

Table 49. South America Rapid Acting Insulins Revenue by Application (2017-2022) & (USD Million)

Table 50. South America Rapid Acting Insulins Revenue by Application (2023-2028) & (USD Million)

Table 51. South America Rapid Acting Insulins Revenue by Country (2017-2022) & (USD Million)

Table 52. South America Rapid Acting Insulins Revenue by Country (2023-2028) & (USD Million)

Table 53. Middle East & Africa Rapid Acting Insulins Revenue by Type (2017-2022) & (USD Million)

Table 54. Middle East & Africa Rapid Acting Insulins Revenue by Type (2023-2028) & (USD Million)

Table 55. Middle East & Africa Rapid Acting Insulins Revenue by Application (2017-2022) & (USD Million)

Table 56. Middle East & Africa Rapid Acting Insulins Revenue by Application (2023-2028) & (USD Million)

Table 57. Middle East & Africa Rapid Acting Insulins Revenue by Country (2017-2022) & (USD Million)

Table 58. Middle East & Africa Rapid Acting Insulins Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Rapid Acting Insulins Picture

Figure 2. Global Rapid Acting Insulins Revenue Market Share by Type in 2021

Figure 3. Lispro

Figure 4. Aspart (NovoLog)

Figure 5. Glulisine (Apidra)

Figure 6. Rapid Acting Insulins Revenue Market Share by Application in 2021

Figure 7. Type 1 Diabetes Picture

Figure 8. Type 2 Diabetes Picture

Figure 9. Global Rapid Acting Insulins Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global Rapid Acting Insulins Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Rapid Acting Insulins Revenue Market Share by Region (2017-2028)

Figure 12. Global Rapid Acting Insulins Revenue Market Share by Region in 2021

Figure 13. North America Rapid Acting Insulins Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe Rapid Acting Insulins Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific Rapid Acting Insulins Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America Rapid Acting Insulins Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa Rapid Acting Insulins Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Rapid Acting Insulins Market Drivers

Figure 19. Rapid Acting Insulins Market Restraints

Figure 20. Rapid Acting Insulins Market Trends

Figure 21. Eli Lilly Recent Developments and Future Plans

Figure 22. Novo Nordisk Recent Developments and Future Plans

Figure 23. Sanofi Recent Developments and Future Plans

Figure 24. Global Rapid Acting Insulins Revenue Share by Players in 2021

Figure 25. Rapid Acting Insulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 26. Global Top 3 Players Rapid Acting Insulins Revenue Market Share in 2021

Figure 27. Global Top 10 Players Rapid Acting Insulins Revenue Market Share in 2021

Figure 28. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 29. Global Rapid Acting Insulins Revenue Share by Type in 2021

Figure 30. Global Rapid Acting Insulins Market Share Forecast by Type (2023-2028)

Figure 31. Global Rapid Acting Insulins Revenue Share by Application in 2021

Figure 32. Global Rapid Acting Insulins Market Share Forecast by Application (2023-2028)

Figure 33. North America Rapid Acting Insulins Sales Market Share by Type (2017-2028)

Figure 34. North America Rapid Acting Insulins Sales Market Share by Application (2017-2028)

Figure 35. North America Rapid Acting Insulins Revenue Market Share by Country (2017-2028)

Figure 36. United States Rapid Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 37. Canada Rapid Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 38. Mexico Rapid Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 39. Europe Rapid Acting Insulins Sales Market Share by Type (2017-2028)

Figure 40. Europe Rapid Acting Insulins Sales Market Share by Application (2017-2028)

Figure 41. Europe Rapid Acting Insulins Revenue Market Share by Country (2017-2028)

Figure 42. Germany Rapid Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 43. France Rapid Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. United Kingdom Rapid Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 45. Russia Rapid Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Italy Rapid Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Asia-Pacific Rapid Acting Insulins Sales Market Share by Type (2017-2028)

Figure 48. Asia-Pacific Rapid Acting Insulins Sales Market Share by Application (2017-2028)

Figure 49. Asia-Pacific Rapid Acting Insulins Revenue Market Share by Region (2017-2028)

Figure 50. China Rapid Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Japan Rapid Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. South Korea Rapid Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. India Rapid Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Southeast Asia Rapid Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Australia Rapid Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. South America Rapid Acting Insulins Sales Market Share by Type (2017-2028)

Figure 57. South America Rapid Acting Insulins Sales Market Share by Application (2017-2028)

Figure 58. South America Rapid Acting Insulins Revenue Market Share by Country (2017-2028)

Figure 59. Brazil Rapid Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Argentina Rapid Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Middle East and Africa Rapid Acting Insulins Sales Market Share by Type (2017-2028)

Figure 62. Middle East and Africa Rapid Acting Insulins Sales Market Share by Application (2017-2028)

Figure 63. Middle East and Africa Rapid Acting Insulins Revenue Market Share by Country (2017-2028)

Figure 64. Turkey Rapid Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Saudi Arabia Rapid Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. UAE Rapid Acting Insulins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Methodology

Figure 68. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz